Some research gets referenced for years — new hires study it, future questions get answered from it, and new projects are built on its foundation. Other research answers the original brief and quietly disappears.The difference rarely comes down to budget, sample size, or methodology. More often, it comes from decisions made before the first question is written.Drawing on experience from both the... See More →
We set out to understand how patients feel about AI in cardiac monitoring. We did it using AI. The irony was instructive. AI-moderated interviews scaled our reach and surfaced patterns quickly, but the most important findings came from traditional focus groups, where facilitators could probe beneath rehearsed answers into real hesitations. This session makes the case for hybrid qual: not AI vs.... See More →
Understanding your product and how it will be perceived is essential to great marketing—but deeply knowing your customers is what unlocks the realm of insights that can create a winning brand strategy. As Gilead has entered new therapeutic areas and indications, its teams have been challenged to re-think long held assumptions about various constituents and inspired to get below the surface to... See More →
Insight teams are often asked, “What should we do differently?” but are forced to answer with disconnected measures. We’ll share an approach that links how strategy is executed in the field, how it is taken out by HCPs, and how it shows up in real-world behavior, so teams can diagnose root cause (execution vs differentiation vs message impact vs targeting) and prioritize interventions that... See More →
This session will feature a fireside-style conversation between Shapiro+Raj and Akari Therapeutics focused on how AI is fundamentally reshaping leadership, decision-making, and operational agility across the pharmaceutical and biotech landscape. Rather than another high-level discussion about the promise of AI, this conversation will explore the practical realities of operating in an increasingly... See More →
Traditional segmentation focuses on clinical attitudes and behaviors in order to identify where customers sit today and how their behavior and attitudes need to be maintained or shifted within the market. This approach often misses two key factors: actionability (the ability to identify these consumer segments in the real world) and influenceability (what drives particular attitudes and behaviors... See More →
What if your team could hear from HCPs — not just during a study, but in the moments when strategic and creative decisions are actually being made? In this session, we'll share how synthetic HCP personas — built on a foundation of existing segmentation research — helped a brand team evaluate creative concepts, compare messaging approaches, and make strategic campaign architecture decisions... See More →